Jazz Pharmaceuticals plc — Director's Dealing 2022

Dec 8, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Jazz Pharmaceuticals plc (JAZZ)
CIK: 0001232524
Period of Report: 2022-12-05

Reporting Person: Swisher Daniel N JR (President and COO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-12-05	Ordinary Shares	J	10465	$0.0	Disposed	46984	Direct

Footnotes

F1: Shares transferred to spouse without consideration as part of a comprehensive division of marital assets in a divorce proceeding.

F2: Includes 147 and 51 ordinary shares acquired under a Section 423 Employee Stock Purchase Plan on May 31 and November 30, 2022, respectively.